News

Alkem Laboratories informs about press release

Alkem Laboratories has informed that the Company has launched Ibuprofen and Famotidine Tablets in the United States, following an approval from the United States Food and Drug Administration (US FDA). A press release in this regard is enclosed on 4th August 2021 titled ‘Alkem Launches Ibuprofen and Famotidine Tablets in the United States’.

The above information is a part of company’s filings submitted to BSE.